Logo image of TRNS

TRANSCAT INC (TRNS) Stock Fundamental Analysis

USA - NASDAQ:TRNS - US8935291075 - Common Stock

69.25 USD
-0.65 (-0.93%)
Last: 10/17/2025, 5:20:02 PM
69.25 USD
0 (0%)
After Hours: 10/17/2025, 5:20:02 PM
Fundamental Rating

5

Overall TRNS gets a fundamental rating of 5 out of 10. We evaluated TRNS against 49 industry peers in the Trading Companies & Distributors industry. While TRNS has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, TRNS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

TRNS had positive earnings in the past year.
In the past year TRNS had a positive cash flow from operations.
Each year in the past 5 years TRNS has been profitable.
Each year in the past 5 years TRNS had a positive operating cash flow.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

TRNS's Return On Assets of 3.41% is in line compared to the rest of the industry. TRNS outperforms 48.98% of its industry peers.
TRNS has a Return On Equity of 4.57%. This is comparable to the rest of the industry: TRNS outperforms 40.82% of its industry peers.
TRNS has a worse Return On Invested Capital (3.98%) than 61.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TRNS is below the industry average of 10.04%.
Industry RankSector Rank
ROA 3.41%
ROE 4.57%
ROIC 3.98%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 4.64%, TRNS is in line with its industry, outperforming 57.14% of the companies in the same industry.
TRNS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 6.59%, TRNS is in line with its industry, outperforming 53.06% of the companies in the same industry.
In the last couple of years the Operating Margin of TRNS has grown nicely.
TRNS has a Gross Margin of 32.14%. This is comparable to the rest of the industry: TRNS outperforms 59.18% of its industry peers.
In the last couple of years the Gross Margin of TRNS has grown nicely.
Industry RankSector Rank
OM 6.59%
PM (TTM) 4.64%
GM 32.14%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRNS is destroying value.
Compared to 1 year ago, TRNS has more shares outstanding
TRNS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRNS has a worse debt to assets ratio.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

An Altman-Z score of 5.30 indicates that TRNS is not in any danger for bankruptcy at the moment.
TRNS has a Altman-Z score of 5.30. This is amongst the best in the industry. TRNS outperforms 85.71% of its industry peers.
TRNS has a debt to FCF ratio of 1.76. This is a very positive value and a sign of high solvency as it would only need 1.76 years to pay back of all of its debts.
TRNS has a better Debt to FCF ratio (1.76) than 81.63% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that TRNS is not too dependend on debt financing.
TRNS's Debt to Equity ratio of 0.11 is fine compared to the rest of the industry. TRNS outperforms 75.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.76
Altman-Z 5.3
ROIC/WACC0.43
WACC9.35%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

TRNS has a Current Ratio of 2.92. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
TRNS has a better Current ratio (2.92) than 75.51% of its industry peers.
TRNS has a Quick Ratio of 2.36. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of TRNS (2.36) is better than 83.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.36
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The earnings per share for TRNS have decreased by -6.51% in the last year.
TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 8.49% in the last year.
Measured over the past years, TRNS shows a quite strong growth in Revenue. The Revenue has been growing by 9.97% on average per year.
EPS 1Y (TTM)-6.51%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%22.92%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%14.57%

3.2 Future

TRNS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.33% yearly.
TRNS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.34% yearly.
EPS Next Y56.64%
EPS Next 2Y33.21%
EPS Next 3Y3.33%
EPS Next 5Y16.33%
Revenue Next Year16.45%
Revenue Next 2Y11.88%
Revenue Next 3Y10.93%
Revenue Next 5Y9.34%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

TRNS is valuated quite expensively with a Price/Earnings ratio of 43.83.
Based on the Price/Earnings ratio, TRNS is valued a bit more expensive than 67.35% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.40, TRNS is valued quite expensively.
The Price/Forward Earnings ratio is 26.55, which means the current valuation is very expensive for TRNS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TRNS indicates a slightly more expensive valuation: TRNS is more expensive than 63.27% of the companies listed in the same industry.
TRNS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 43.83
Fwd PE 26.55
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

63.27% of the companies in the same industry are cheaper than TRNS, based on the Enterprise Value to EBITDA ratio.
TRNS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 32.99
EV/EBITDA 17.51
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

TRNS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.77
PEG (5Y)6.89
EPS Next 2Y33.21%
EPS Next 3Y3.33%

0

5. Dividend

5.1 Amount

TRNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRANSCAT INC

NASDAQ:TRNS (10/17/2025, 5:20:02 PM)

After market: 69.25 0 (0%)

69.25

-0.65 (-0.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03
Inst Owners95.92%
Inst Owner Change-0.03%
Ins Owners0.99%
Ins Owner Change1.01%
Market Cap645.41M
Analysts78.18
Price Target111.59 (61.14%)
Short Float %4.94%
Short Ratio4.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.54%
Min EPS beat(2)2.65%
Max EPS beat(2)46.44%
EPS beat(4)2
Avg EPS beat(4)-0.21%
Min EPS beat(4)-25.94%
Max EPS beat(4)46.44%
EPS beat(8)5
Avg EPS beat(8)-0.38%
EPS beat(12)7
Avg EPS beat(12)3%
EPS beat(16)9
Avg EPS beat(16)5.31%
Revenue beat(2)1
Avg Revenue beat(2)1.32%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)3.66%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-6.92%
Max Revenue beat(4)3.66%
Revenue beat(8)3
Avg Revenue beat(8)-1.9%
Revenue beat(12)5
Avg Revenue beat(12)-1.22%
Revenue beat(16)7
Avg Revenue beat(16)-0.8%
PT rev (1m)0%
PT rev (3m)0.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.96%
EPS NY rev (1m)6.19%
EPS NY rev (3m)26.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.98%
Valuation
Industry RankSector Rank
PE 43.83
Fwd PE 26.55
P/S 2.24
P/FCF 32.99
P/OCF 19.16
P/B 2.21
P/tB 10.17
EV/EBITDA 17.51
EPS(TTM)1.58
EY2.28%
EPS(NY)2.61
Fwd EY3.77%
FCF(TTM)2.1
FCFY3.03%
OCF(TTM)3.61
OCFY5.22%
SpS30.92
BVpS31.39
TBVpS6.81
PEG (NY)0.77
PEG (5Y)6.89
Profitability
Industry RankSector Rank
ROA 3.41%
ROE 4.57%
ROCE 5.2%
ROIC 3.98%
ROICexc 4.01%
ROICexgc 10.83%
OM 6.59%
PM (TTM) 4.64%
GM 32.14%
FCFM 6.79%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexcg growth 3Y-9.42%
ROICexcg growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.76
Debt/EBITDA 0.85
Cap/Depr 70.4%
Cap/Sales 4.9%
Interest Coverage 250
Cash Conversion 86.24%
Profit Quality 146.34%
Current Ratio 2.92
Quick Ratio 2.36
Altman-Z 5.3
F-Score4
WACC9.35%
ROIC/WACC0.43
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.51%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%22.92%
EPS Next Y56.64%
EPS Next 2Y33.21%
EPS Next 3Y3.33%
EPS Next 5Y16.33%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%14.57%
Revenue Next Year16.45%
Revenue Next 2Y11.88%
Revenue Next 3Y10.93%
Revenue Next 5Y9.34%
EBIT growth 1Y-13.17%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year191.83%
EBIT Next 3Y38.68%
EBIT Next 5Y27.44%
FCF growth 1Y54.5%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y50.08%
OCF growth 3Y30.31%
OCF growth 5Y27.52%